Fresenius Medical Care (NYSE: FMS) reported Q4 EPS of EUR1.36, versus EUR1.29 reported last year. Revenue for the quarter came in at EUR4.58 billion, versus EUR4.3 billion reported last year.

Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: “2019 was a successful year for Fresenius Medical Care. We achieved our revenue and net income targets and are therefore proposing our 23rd consecutive dividend increase. Last year we also invested more strongly in our future growth, particularly in the area of home dialysis and in developing economies. In addition, our measures to increase efficiency and optimize our cost base are progressing according to plan. As a consequence, we expect growth to accelerate, and confirm the 2020 outlook that we issued early last year.”

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.